VASP and renal cell carcinoma: Controversially, Zhao et al. [17] demonstrated that overexpression of ANGPTL3 suppressed metastasis in renal cell carcinoma (RCC) cells through modulation of vasodilator-stimulated phosphoprotein phosphorylation.